Articles from VB Spine LLC

VB Spine LLC (“VB Spine”), the largest privately held spine company, will showcase its xvision X2 headset at the North American Spine Society’s (NASS) 41st Annual Meeting, October 14–17, 2026, in San Antonio, Texas, at booth #701. The company will also highlight its Vulcan™ Spinal System, a spinal fixation system designed for thoracolumbar procedures.

VB Spine LLC (“VB Spineˮ), the largest privately held spine company, today announced the appointment of Thomas E. Oglesby as Chief Financial Officer, effective Sept. 16, 2026. Oglesby joins VB Spine from Zimmer Biomet, where he most recently served as Vice President, Finance for the company's Sports, Extremities and Trauma global business unit.

VB Spine LLC (“VB Spine”) today announced that the U.S. Food and Drug Administration (FDA) granted two 510(k) clearances that expand the indications for its Vitoss® Bone Graft Substitute and interbody cage portfolio. The clearances allow Vitoss® to be used in the intervertebral disc space with interbody cages and expand the indications for VB Spine’s interbody cages to include use with bone void fillers cleared for use in intervertebral body fusion procedures, including Vitoss®.

VB Spine LLC (“VB Spine”), a global, family-owned spine company, today announced that its European Distribution Center began shipping orders across Europe this month; the distribution center began accepting orders on June 1, 2026. Now that the center is fully operational, it serves as the primary center for VB Spine product distribution to customers in Europe.

VB Spine LLC (“VB Spine”) today announced it has entered into a definitive agreement to acquire the exclusive rights to Augmedics’ CT-to-fluoroscopy (CT-Fluoro) technology for spine applications.

VB Spine LLC (“VB Spine”), a global, family-owned spine company, today announced that it has signed a Master Service Agreement with Apolo Medica to begin distribution of VB Spine products in Mexico. The announcement follows VB Spine’s recent expansion into the Netherlands, Luxembourg, Belgium, Australia, and New Zealand.

VB Spine LLC (“VB Spine”), today launched VB Spine Solutions, a program designed to bring critical spine technology to hospitals faster, with structures built around patient need.

VB Spine LLC (“VB Spine”) completed its acquisition of exclusive rights to the xvision Spine System® (xvision) from Augmedics.

VB Spine LLC (“VB Spine”), today announced the successful completion of the first clinical cases utilizing the Vulcan™ Spinal System for thoracolumbar fixation. The milestone marks the system’s entry into Limited Market Release and represents a significant step forward in the company’s strategy to expand its next-generation implant portfolio.

VB Spine LLC (“VB Spine”), the largest privately held spine company, today announced it has entered into a definitive agreement to acquire exclusive rights to the xvision Spine System® (xvision) from Augmedics, adding augmented reality (AR) navigation to VB Spine’s growing enhanced visualization portfolio. Augmedics is the first company to offer an FDA-cleared AR navigation platform in spine surgery, positioning VB Spine to become a world leader in AR-enabled spine solutions. The transaction is subject to approval and customary closing conditions and is expected to close in the coming weeks.

VB Spine LLC (“VB Spine”) today announced an agreement to acquire the SpineHawk™ platform from Robotron Surgical Technologies, expanding VB Spine’s portfolio with intraoperative spinal visualization and a software roadmap intended to support technology-enabled spine care. Robotron Surgical Technologies, a developer of advanced spinal endoscopy surgical systems, originated the SpineHawk platform as part of its broader work in AI-powered visualization.

VB Spine LLC (“VB Spine”) today completed the acquisition of Stryker’s spine implant manufacturing facility in Cestas, France. Known for its state-of-the-art operations and technical capabilities, the Cestas facility will play a central role in VB Spine’s global manufacturing strategy.

VB Spine LLC (“VB Spine”), a global, family-led spine company dedicated to advancing patient outcomes, announced the completion of the sale of Stryker’s spinal implants business in Australia and New Zealand. This milestone builds upon the formation of VB Spine on April 1, 2025, following the acquisition of Stryker’s U.S. spinal implants business by Viscogliosi Brothers, LLC. It also marks VB Spine’s first market entry outside the United States and establishes a direct presence in two fast-growing markets.